Biogen to Present Data at Virtual 2020 Alzheimer’s Association International Conference Highlighting Comprehensive Approach to Alzheimer’s DiseaseGlobeNewsWire • 07/24/20
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/22/20
Biogen Names Michael McDonnell as Executive Vice President and Chief Financial OfficerGlobeNewsWire • 07/21/20
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (onasemnogene abeparvovec)GlobeNewsWire • 07/21/20
Is Biogen Stock A Buy Now That Its Alzheimer's Drug Is In FDA's Court?Investors Business Daily • 07/16/20
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALSGlobeNewsWire • 07/08/20